There was a lot of information on the slide deck. If you look at how it is assembled you will see how robust the argment is for the technology. Its not an early study either. Its a phase 2 assets with 140 patients and 9 clinical trials. That is not early. That is make it test it done. This also has immunmodulating activity but in my opinion not as strong as CCR5. That basically puts the macrophages in jail while the signal fires are buring in the lungs. Without the macrophages to tend to the fire they eventually die down.

So Bioxytran as a galectin inhibitor that gunks up the virus and then the liver filters the sugar which is attached to the virus out of the body. We could be months away from this therapy if they get funding. Thanks for looking at it but you need to look at whats coming around the corner so you know what you have. This is not a threat to CYDY its is something that will save the rest of the world with a cheap effective solution to cleaning the virus out of everyones system all at once. This is also a prophylaxis.